Skip to Content

View Additional Section Content

Lupus Anticoagulant *




85613; 85732 


Lupus Ag; Lupus Anticoagulant screen; Lupus Anticoagulant with reflex 

Specimen Type



Blue-top (sodium citrate) tube

Collection Instructions

Blue-top tube containing 3.2% buffered sodium citrate. Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio. Sample should be mixed by gentle inversion at least six times to ensure adequate mixing.


Volume: 6 ml. 
Min. volume: 3 ml. (this does not allow for repeat testing) 

Additional Information

Lupus anticoagulants are nonspecific antibodies that extend the clotting time of phospholipid-dependent clotting assays such as the aPTT. Unlike specific factor antibodies, LA are usually associated with venous thrombosis. 
This is not the Lupus with Cardiolipin.

Patient Preparation

 Ideally the patient should not be on anticoagulant therapy. Avoid warfarin (Coumadin®)therapy for two weeks and heparin direct Xa and theombin therapies for three days prior to the test.

Specimen Processing Instructions

 Once in the lab, separate plasma from cells as soon as possible. Double centrifugation is necessary for citrated plasma samples for this assay.

Transport Requirements

Frozen only

Specimen Stability

7 days 

Rejection Criteria

Hemolysis; clotted specimen; specimen received not frozen; serum

Reference Range

Reference range accompanies report

Critical Value


Test Includes

The qualitative detection of lupus anticoagulants in plasma 


PTT-LA(lupus-sensitive aPTT) and drVVT screen; mixing study if screening tests are prolonged; confirmation if the mixing studies do not correct. 

Testing Frequency




Reviewed By

Lisa McBride                

Reviewed Date



*  Denotes Reference Lab Test

This test is not the same as the Lupus Anticoagulant Comprehensive Panel.

Reviewed by Lisa McBride on February 20, 2018

Was this page helpful?


Thank you for your feedback!

Thank you for your feedback and helping us to improve our website.
There will be no additional response.